These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 17890476)
1. Effects of short-acting bronchodilators added to maintenance tiotropium therapy. Kerstjens HA; Bantje TA; Luursema PB; Sinninghe Damste HE; de Jong JW; Lee A; Wijker SP; Cornelissen PJ Chest; 2007 Nov; 132(5):1493-9. PubMed ID: 17890476 [TBL] [Abstract][Full Text] [Related]
2. Concomitant use of ipratropium and tiotropium in chronic obstructive pulmonary disease. Cole JM; Sheehan AH; Jordan JK Ann Pharmacother; 2012 Dec; 46(12):1717-21. PubMed ID: 23170031 [TBL] [Abstract][Full Text] [Related]
3. Acute effects of higher than standard doses of salbutamol and ipratropium on tiotropium-induced bronchodilation in patients with stable COPD. Cazzola M; Santus P; D'Adda A; Pizzolato S; Di Marco F; Centanni S Pulm Pharmacol Ther; 2009 Jun; 22(3):177-82. PubMed ID: 19038356 [TBL] [Abstract][Full Text] [Related]
4. Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in Taiwan. Hsu JY; Perng RP; Lu JY; Wu CP; Huang MS; Luh KT; Yang PC J Formos Med Assoc; 2006 Sep; 105(9):708-14. PubMed ID: 16959618 [TBL] [Abstract][Full Text] [Related]
5. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group. Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576 [TBL] [Abstract][Full Text] [Related]
6. [The effect of inhaled anticholinergic drugs (tiotropium bromide) on asthma patients with persistent obstructive ventilatory impairment]. Nogami H; Honjo S; Iwanaga T Arerugi; 2012 Nov; 61(11):1675-82. PubMed ID: 23328224 [TBL] [Abstract][Full Text] [Related]
7. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD. Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436 [TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease. van Noord JA; Smeets JJ; Custers FL; Korducki L; Cornelissen PJ Eur Respir J; 2002 Apr; 19(4):639-44. PubMed ID: 11998992 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities]. Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N; Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease]. Zheng JP; Kang J; Cai BQ; Zhou X; Cao ZL; Bai CX; Zhong NS Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):363-7. PubMed ID: 17045014 [TBL] [Abstract][Full Text] [Related]
12. Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease. Matsushima S; Inui N; Yasui H; Kono M; Nakamura Y; Toyoshima M; Shirai T; Suda T Pulm Pharmacol Ther; 2015 Feb; 30():11-5. PubMed ID: 25445929 [TBL] [Abstract][Full Text] [Related]
13. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease. Ikeda A; Nishimura K; Koyama H; Izumi T Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652 [TBL] [Abstract][Full Text] [Related]
14. The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD. Singh D; Abbott-Banner K; Bengtsson T; Newman K Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30166326 [TBL] [Abstract][Full Text] [Related]
15. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD. Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763 [TBL] [Abstract][Full Text] [Related]
16. Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study. Singh D; Zhu CQ; Sharma S; Church A; Kalberg CJ Pulm Pharmacol Ther; 2015 Apr; 31():85-91. PubMed ID: 25197005 [TBL] [Abstract][Full Text] [Related]
17. Tiotropium bromide: a long-acting anticholinergic bronchodilator for the treatment of patients with chronic obstructive pulmonary disease. Joos GF; Brusselle G; Derom E; Pauwels R Int J Clin Pract; 2003 Dec; 57(10):906-9. PubMed ID: 14712894 [TBL] [Abstract][Full Text] [Related]
18. Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD. Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF Pulm Pharmacol Ther; 2014 Aug; 28(2):158-64. PubMed ID: 24076367 [TBL] [Abstract][Full Text] [Related]
19. Effects of tiotropium and formoterol on quiet breathing pattern assessed by optoelectronic plethysmography in COPD patients: a pilot study. Dal Negro RW; Turati C; Micheletto C; Menegoni F Ther Adv Respir Dis; 2012 Apr; 6(2):97-105. PubMed ID: 22250038 [TBL] [Abstract][Full Text] [Related]
20. Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease? Tashkin DP Curr Opin Pulm Med; 2005 Mar; 11(2):121-8. PubMed ID: 15699783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]